Utility of transesophageal echocardiography in the identification and treatment of occult mechanisms of cerebral infarction.

Autor: Heslin ME; Cooper Medical School of Rowan University, Camden, NJ 08103, USA. Electronic address: heslinm6@rowan.edu., Thon JM; Cooper Neurological Institute, Department of Internal Medicine, Cooper University Hospital, Camden, NJ 08103, USA., Caruso E; Cooper Neurological Institute, Department of Internal Medicine, Cooper University Hospital, Camden, NJ 08103, USA., Romiyo P; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Rana A; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Yu S; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Thau L; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Rana A; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Kamen S; Cooper Medical School of Rowan University, Camden, NJ 08103, USA., Siegler JE; Cooper Neurological Institute, Department of Internal Medicine, Cooper University Hospital, Camden, NJ 08103, USA.
Jazyk: angličtina
Zdroj: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2022 Jan; Vol. 95, pp. 31-37. Date of Electronic Publication: 2021 Dec 03.
DOI: 10.1016/j.jocn.2021.10.020
Abstrakt: Cryptogenic stroke comprises approximately 25% of all cases of ischemic stroke. The diagnostic evaluation of these patients remains a challenge in clinical practice. Transesophageal echocardiography (TEE) has been shown to have superior diagnostic accuracy in identifying potential cardioembolic sources of ischemic stroke when compared to transthoracic echocardiography (TTE). However, there has been inconsistent data on the management implications of these new cardiac findings. The addition of TEE to the comprehensive stroke evaluation will better identify potential cardiac sources of embolism (CSE) and will result in significant management changes. A prospective registry of consecutively admitted patients with acute ischemic stroke (1/1/2015-8/10/2020) was retrospectively queried. Patients 18 to 60 years of age with stroke due to mechanisms other than large or small vessel disease, or atrial fibrillation were eligible for inclusion. The primary outcome was any high-risk CSE identified on TEE following unrevealing TTE. Of the 2,404 consecutive stroke patients evaluated during the study period, 263 (11%) met inclusion criteria and the median age was 53 (IQR 46-57). TEE was performed in 108 patients (41%). A high-risk CSE was identified in 36 patients (33%), the majority of which were PFOs (n = 29). TEE led to a clinical management change in 14 patients (39%) after identification of a high-risk CSE; 6 underwent PFO closure and 8 had adjustment to their antithrombotic therapy. The addition of TEE to the comprehensive stroke evaluation led to the identification of a high-risk CSE in one in three patients resulting in significant management changes.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2021 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: